###begin article-title 0
###xml 49 54 <span type="species:ncbi:9606">Human</span>
Characterization of a Natural Mutator Variant of Human DNA Polymerase lambda which Promotes Chromosomal Instability by Compromising NHEJ
###end article-title 0
###begin p 1
Conceived and designed the experiments: TK JSH LB. Performed the experiments: GT JPC YC MGD KB TK FB VB. Wrote the paper: JSH LB. Supervised research: KB AV CC TK JSH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
DNA polymerase lambda (Pollambda) is a DNA repair polymerase, which likely plays a role in base excision repair (BER) and in non-homologous end joining (NHEJ) of DNA double-strand breaks (DSB).
###end p 3
###begin title 4
Principal Findings
###end title 4
###begin p 5
###xml 233 241 223 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 54 59 <span type="species:ncbi:9606">human</span>
Here, we described a novel natural allelic variant of human Pollambda (hPollambda) characterized by a single nucleotide polymorphism (SNP), C/T variation in the first base of codon 438, resulting in the amino acid change Arg to Trp. In vitro enzyme activity assays of the purified W438 Pollambda variant revealed that it retained both DNA polymerization and deoxyribose phosphate (dRP) lyase activities, but had reduced base substitution fidelity. Ectopic expression of the W438 hPollambda variant in mammalian cells increases mutation frequency, affects the DSB repair NHEJ pathway, and generates chromosome aberrations. All these phenotypes are dependent upon the catalytic activity of the W438 hPollambda.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
The expression of a cancer-related natural variant of one specialized DNA polymerase can be associated to generic instability at the cromosomal level, probably due a defective NHEJ. These results establish that chromosomal aberrations can result from mutations in specialized DNA repair polymerases.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 147 150 147 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Hoeijmakers1">[1]</xref>
###xml 421 424 421 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Hubscher1">[2]</xref>
###xml 634 637 634 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Shcherbakova1">[3]</xref>
###xml 755 758 750 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz1">[4]</xref>
###xml 759 762 754 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Nagasawa1">[6]</xref>
###xml 939 942 926 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz2">[7]</xref>
###xml 1133 1136 1112 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz3">[8]</xref>
###xml 1193 1196 1164 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz4">[9]</xref>
###xml 1253 1257 1224 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Beard1">[10]</xref>
###xml 1258 1262 1229 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Braithwaite2">[13]</xref>
###xml 1341 1344 1304 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz1">[4]</xref>
###xml 1346 1350 1309 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Callebaut1">[14]</xref>
###xml 1352 1356 1315 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Bork1">[15]</xref>
###xml 1410 1414 1373 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Fan1">[16]</xref>
###xml 1415 1419 1378 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-NickMcElhinny1">[18]</xref>
###xml 1523 1527 1481 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Lee1">[19]</xref>
###xml 1688 1692 1641 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Capp1">[20]</xref>
###xml 1500 1505 <span type="species:ncbi:9606">human</span>
The maintenance of genome integrity is dependent on numerous mechanisms, which notably allow fidelity of DNA replication and repair of damaged DNA [1]. Those processes require a large number of proteins including DNA polymerases. Nevertheless, the recent discovery that eukaryotic cells contain many more DNA polymerases than previously thought added further complexity to our appreciation of DNA transactions (review in [2]). Function of those recently discovered DNA polymerases remain still uncertain but numerous connections between their regulation, organisation, and coordinated action for DNA protection have been already made [3]. A novel family X DNA polymerase, named Pollambda, has been independently identified in three different laboratories [4]-[6]. Pollambda forms a Polbeta-like core that consists of two domains: 31 kDa polymerization domain (bearing the three conserved subdomains: fingers, palm, thumb) and 8 kDa domain [7]. In agreement with their structural relationships (32% amino acid identity), the biochemical properties of Pollambda are partly similar to those of Polbeta, and suggest a role in DNA repair [8]. Indeed, as Polbeta, Pollambda has a dRP lyase activity [9], and accordingly, these enzymes both have a role in BER [10]-[13]. However, unlike Polbeta, Pollambda contains a BRCA1 C-terminal (BRCT) domain [4], [14], [15], required for a stable interaction with NHEJ factors [16]-[18]. Moreover, Pollambda is able to perform alignment-based gap filling for NHEJ in human nuclear extracts [19], and the expression in mammalian cells of a catalytically inactive form of Pollambda decreases the frequency of NHEJ events in response to I-Sce-I -induced DSB [20]. All these features support a potential role for Pollambda in the NHEJ repair of DSB.
###end p 9
###begin p 10
###xml 336 340 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Dobashi1">[21]</xref>
###xml 341 345 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Sweasy1">[24]</xref>
###xml 469 477 461 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
A number of polymorphic variants have been described in several DNA repair genes that could -when adequately combined- substantially alter overall DNA repair capacity. Conversely, few reports exist on the identification and characterization of polymorphic or altered isoforms of the known DNA polymerases, with the exception of Polbeta [21]-[24]. Here, we report the identification of a natural allelic variant of hPollambda that has reduced base substitution fidelity in vitro and whose expression in cultured cells increases mutation frequency and compromises the DSB repair pathway NHEJ, resulting in radiosensitivity and chromosomal instability.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
Identification of a SNP in the coding region of hPollambda
###end title 12
###begin p 13
###xml 268 275 258 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g001">Fig. 1A</xref>
###xml 356 365 346 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g001">Figure 1B</xref>
###xml 899 901 884 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 928 935 913 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g001">Fig. 1B</xref>
Several normal and tumoral cDNA samples were screened for possible nucleotide changes in the hPollambda gene. The complete coding region of hPollambda, comprising exons 1 to 9, was amplified by polymerase chain reaction (PCR) in five overlapping fragments, named a-e (Fig. 1A), and subjected to single-stranded conformational polymorphism (SSCP) analysis. Figure 1B illustrates a representative analysis using non-paired normal and tumor ovarian tissues. As shown, fragments a, b, c and d, covering the first seven exons of hPollambda, did not produce any band with altered mobility when normal and tumoral samples were compared. Moreover, no mobility alteration was detected for fragments a-d in any other tissues analyzed. However, PCR-SCCP analysis of fragment e (covering exon 8 and the first half of exon 9 of the transcript) identified an abnormal mobility pattern when comparing normal ovary vs ovarian carcinoma GI-101 (Fig. 1B). The same variation in the PCR-SSCP profile for fragment e was identified using other tissues from the normal and tumoral panel.
###end p 13
###begin title 14
PCR/SSCP analysis of the coding region of hPollambda gene.
###end title 14
###begin p 15
###xml 119 140 119 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
(A) Five overlapping fragments, named a-e, covering the whole coding region of the gene were amplified as described in Materials and Methods. (B) SSCP analysis of fragments a-e from non-paired normal (N) and ovarian tumor (T) samples. Only fragment e showed an altered mobility pattern (indicated by arrows). (C) Sequencing of fragment e identified a single nucleotide change (C->T) at nucleotide position 1311 of the cDNA sequence that changes the wild-type arginine residue (R438) to a tryptophane (W438).
###end p 15
###begin p 16
###xml 255 262 250 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g001">Fig. 1C</xref>
Sequence analysis of the PCR fragment e, revealed the existence of a SNP, C to T variation in nucleotide position 1311 (exon 8) of the coding region of hPollambda, resulting in a single arginine (R) to tryptophan (W) amino acid substitution in codon 438 (Fig. 1C). SNP reported here has been designated rs3730477 (), and is one of the two SNPs altering the coding sequence identified to date in hPollambda.
###end p 16
###begin title 17
hPollambda W438 variant has normal polymerase and dRP lyase activities
###end title 17
###begin p 18
###xml 77 81 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Braithwaite1">[12]</xref>
###xml 83 87 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Braithwaite2">[13]</xref>
###xml 160 163 155 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz3">[8]</xref>
###xml 165 168 160 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz4">[9]</xref>
###xml 312 319 307 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 485 492 480 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g002">Fig. 2A</xref>
###xml 663 672 653 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g002">Fig. 2B,C</xref>
###xml 785 793 775 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 863 870 848 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g002">Fig. 2D</xref>
###xml 1035 1044 1020 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007290.s001">Figure S1</xref>
###xml 1214 1222 1194 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 312 319 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 614 619 <span type="species:ncbi:9606">human</span>
Pollambda has been proposed to be a suitable candidate to participate in BER [12], [13], as it contains both gap-filling DNA synthesis and dRP lyase activities [8], [9]. To address if the W438 mutation affects any of these activities, the wild-type form (R438) and the W438 allelic variant were overexpressed in E. coli cells and purified in parallel to compare their biochemical properties. Both enzymes showed a similar DNA polymerization capacity, and a similar affinity for dNTPs (Fig. 2A). Furthermore, both hPollambda forms were capable to excise a dRP residue, generated by the 5' cleavage of an AP site by human apurinic/apyrimidinic endonuclease (hAPE) (Fig. 2B,C). The combination of polymerization and dRP lyase activities present in the W438 variant allows to complete BER in vitro as efficiently as in the case of the R438 wild-type hPollambda form (Fig. 2D). Moreover, there was no diference between the two isoforms in the capacity to insert either dCTP or dATP in front of a 8-oxoG lesion, or in its further extension (Figure S1). Therefore, we can conclude that substitution of arginine 438 to tryptophane in hPollambda, as it occurs in the natural W438 variant, does not significantly affect its in vitro catalytic efficiency.
###end p 18
###begin title 19
Enzymatic activities of the hPollambda W438 variant.
###end title 19
###begin p 20
###xml 296 317 286 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 708 716 698 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1058 1066 1043 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1234 1242 1214 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
(A) DNA polymerization activity of the two allelic variants of hPollambda. DNA polymerase activity of each independent hPollambda variant (R438 or W438), measured as dNMP incorporation on activated DNA, was estimated as a function of enzyme (top) and dNTP (bottom) concentration, as described in Materials and Methods. The first experiment, in which the only dNTP provided was TTP (13,3 nM), demonstrates that nucleotide insertion was linear for both variants, in the interval of 30-120 ng of enzyme. The second experiment, using 60 ng of each enzyme variant, tested polymerization of the four dNTPs at various (from limiting to saturating) concentrations. (B-D) dRP lyase activity and reconstitution of BER in vitro with the two allelic variants of hPollambda: (B) The scheme shows a 34-mer double-stranded oligonucleotide containing an uracil residue (at position 16) in the strand which is 3'-end labeled (*). After treatment with UDG and hAPE, a dRPcontaining nicked substrate (19mer+dRP) is obtained, that can be a substrate for dRP lyase activity. (C) In vitro analysis of the dRP lyase reaction. As shown in the autoradiogram, the dRP moiety can be cleaved by incubation with either variant (R or W) of hPollambda (30 nM). (D) In vitro reconstitution of a BER reaction. A non-labeled 34-mer double-stranded oligonucleotide containing a uracil residue at position 16 in one strand is treated with UDG (100 nM) and hAPE (40 nM) to release a dRP-containing nicked substrate. By adding a labeled dNTP (alpha-dCTP) and either purified hPollambda R or hPollambda W variants (60 nM), two labeled products can be observed after denaturing electrophoresis and autoradiography: (i) a 16-mer product generated by a single nucleotide insertion at the 3-hydroxyl end of the 5-incised AP site; (ii) a 34-mer product that corresponds to the complete repair of the DNA strand upon T4 DNA ligase action.
###end p 20
###begin title 21
hPollambda W438 has a lower fidelity than hPollambda R438
###end title 21
###begin p 22
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Kunkel1">[25]</xref>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Ponamarev1">[26]</xref>
###xml 378 382 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Osheroff1">[27]</xref>
###xml 383 387 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Dalal1">[32]</xref>
###xml 660 664 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Osheroff1">[27]</xref>
###xml 666 670 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Osheroff2">[28]</xref>
###xml 855 857 840 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 890 892 868 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 1113 1120 1081 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007290-t001">Table 1</xref>
A major property of DNA-dependent DNA polymerases is their DNA synthesis fidelity. It has been shown that a decrease in the fidelity of a particular DNA polymerase can lead to detrimental cellular effects, including cell death, cancer, and other genetic diseases [25], [26]. Moreover, several examples exist of point mutations in Polbeta causing a dramatic decrease in fidelity [27]-[32]. To determine whether the tryptophan substitution at position 438 affects hPollambda fidelity, we measured base substitution and insertion-deletion error rates by the wild-type (R438) and the W438 hPollambda during a short gap filling reactions in M13mp2 reversion assays [27], [28]. Base substitution errors that revert a TGA codon encoding a faint blue plaque phenotype are scored as dark blue revertants. The DNA products yielded mutant frequencies of 9.0+/-4.4x10-4 (hPollambda R438) and 31+/-12x10-4 (hPollambda W438), as an average of four independent determinations (p = 0.0007). Sequence analysis of DNA amplified from blue-plaque revertants allows error rates to be calculated for each hPollambda form. The results (Table 1) indicate that, in comparison to the wild-type, the W438 variant is less accurate for T to C and G to T substitutions by factors of 4-fold (p = 0.001) and 8-fold (p<0.022), respectively. In contrast, the insertion-deletion mutant frequencies of the two forms were similar (data not shown) when examined using a 6-nucleotide gap-filling substrate containing a template TTTT run in the +1 reading frame.
###end p 22
###begin title 23
###xml 57 62 <span type="species:ncbi:9606">human</span>
Base substitution specificity of allelic variant W438 of human Pollambda during short gap filling synthesis.
###end title 23
###begin p 24
###xml 43 45 38 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
Mutation Frequency (Pollambda R438): 9.8x10-4.
###end p 24
###begin p 25
###xml 45 47 40 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
Mutation Frequency (Pollambda W438): 22.05x10-4.
###end p 25
###begin p 26
Total sequenced: Pollambda R438->42; Pollambda W438->96.
###end p 26
###begin p 27
###xml 184 186 184 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 199 201 199 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
The error rates are calculated based on sequencing mutants from two different reactions with each enzyme, and using the average mutant frequency for those two experiments, i.e., 9.8x10-4 and 22.05x10-4 for Pollambda R438 and Pollambda W438, respectively.
###end p 27
###begin p 28
###xml 107 114 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 466 469 451 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz1">[4]</xref>
###xml 540 547 520 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g003">Fig. 3A</xref>
###xml 978 979 953 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
###xml 981 985 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Canitrot1">[33]</xref>
###xml 987 996 962 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g003">Figure 3B</xref>
###xml 1265 1269 1237 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Canitrot1">[33]</xref>
###xml 1386 1393 1358 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1414 1421 1386 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g003">Fig. 3B</xref>
###xml 1511 1532 1483 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 1576 1583 1548 1555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g003">Fig. 3B</xref>
###xml 1697 1705 1664 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 244 259 <span type="species:ncbi:10029">Chinese hamster</span>
###xml 427 433 <span type="species:ncbi:10090">murine</span>
We next investigated whether overexpression of the hPollambda W438 variant could affect mutation frequency in vivo. Thus, an eukaryotic expression vector harbouring the W438 variant or the R438 wild-type form of hPollambda was transfected into Chinese hamster ovary (CHO) cells to obtain isogenic strains expressing each isoform (R1 and R2, for R438; W1 and W2, for the W438 variant). Immunoblotting of cellular extracts using murine Pollambda polyclonal antibodies [4] confirmed similar hPollambda levels in all overexpressing cell lines (Fig. 3A). The poor detection of the endogenous hamster Pollambda in the control strains Dra10 and CT (transfected with the empty vector) precluded a proper quantification of the absolute ectopic expression levels. We next measured the frequency of spontaneous mutations by the conventional hypoxanthine phosphoribosyl transferase (HPRT) methodology that tests the appearance of a mutational event leading to 6-thioguanine resistance (6-TGR) [33]. Figure 3B shows that the mutation frequency corresponding to clones R1 and R2 was 2- to 3- fold higher than in control cell lines (clones DRA10 and CT). This agrees with previous data showing that Polbeta overproduction increases (up to 4-fold) mutagenesis using the same assay [33]. More interestingly, overexpression of the W438 variant (clones W1 and W2) produced up to an 8-fold increase in the in vivo mutation frequency (Fig. 3B). Importantly, expression of a polymerization-deficient W438 variant (clone WD; see also Materials and Methods) did not produce such a mutation increase (Fig. 3B). Overall, these results show that cells expressing the W438 variant form of hPollambda, shown to be error-prone in vitro, acquire increased mutability.
###end p 28
###begin title 29
###xml 53 60 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
The W438 variant of hPollambda increases mutagenesis in vivo.
###end title 29
###begin p 30
###xml 496 497 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 858 860 834 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 868 870 844 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 878 880 854 856 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
(A) Immunoblotting of hPollambda in the cell lines overexpressing hPollambda R438 (R1 and R2) and W438 (W1, W2 and the catalytic inactive WD) as compared to control CHO-Dra10 and CT cells (cells transfected with the empty expression vector). As the endogenous levels of hamster Pollambda were not detectable, normalization was carried out with actin antibodies. (B) Mutation frequency of hPollambda-overexpressing clones. To determine spontaneous mutagenesis, cells were plated at a density of 106 cells and exposed to 20 microM 6TG-containing media in order to count the number of HPRT mutants. After 1 additional week, macroscopic colonies were scored and mutation frequencies were calculated by correcting for plating efficiency. The data presented is the average of three independent experiments. The p values relative to the control CT are 0.019, 4.6 10-3, 3.1 10-3, 1.3 10-4, and 0.045, for R1, R2, W1, W2 and WD, respectively.
###end p 30
###begin title 31
3D-structure of the W438 hPollambda variant
###end title 31
###begin p 32
###xml 96 100 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz5">[34]</xref>
###xml 199 208 194 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007290.s002">Figure S2</xref>
###xml 1606 1610 1585 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Shah1">[35]</xref>
###xml 2046 2051 <span type="species:ncbi:9606">human</span>
The structure of hPollambda in complex with DNA and an incoming dNTP has recently been reported [34]. This structure indicates that R438 is a surface residue located in a loop of the palm subdomain (Figure S2). The B-factors in this loop are high, suggesting a certain degree of disorder and, in fact, the density for R438 was not sufficient to build the entire side chain. To try to understand the effects of the R438W substitution we crystallized the 39 kDa domain of the W438 variant under the same conditions already reported for the R438. We were able to obtain crystals that diffracted to low (2.8 A) resolution. The density was of sufficient quality to assess that the overall fold of the W438 variant is identical to that of the R438 wild-type form, indicating that the R438W substitution does not result in a major conformational alteration (the rmsd between the R and W structures is 0.509 for 324 C-a atoms). However, the loop containing residue 438 had a high degree of disorder and no density was observed for the W438 side chain (not shown), suggesting that the R438W substitution might result in local structural alterations. It can be speculated that such a flexibility could be relatable to a necessary conformational change of this loop (that could be altered by the W438 polymorphism), required to form the enzyme:DNA:dNTP ternary complex and thus having an impact on polymerization fidelity. Interestingly, this loop is located next to the N-terminal end of alpha-helix M in hPollambda, and it is known that a mutation in this alpha-helix in Polbeta can severely affect enzyme fidelity [35]. Amino acid sequence comparison of DNA polymerases lambda from different species indicates that an arginine residue is not highly conserved, being substituted for some other amino acid residues as, lysine, glutamine, and even alanine. As a tryptophane is not included among the wild-type options, we would favour that the observed effects are probably due to that particular bulky aromatic amino acid (tryptophane) substitution of the human Pollambda W438 variant.
###end p 32
###begin title 33
Expression of the W438 hPollambda variant reduces cellular NHEJ activity
###end title 33
###begin p 34
###xml 171 177 166 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g003">Fig. 3</xref>
###xml 381 388 371 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g004">Fig. 4A</xref>
###xml 462 471 452 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007290.s003">Figure S3</xref>
###xml 619 621 609 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KD</sup>
###xml 629 638 619 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007290.s003">Figure S3</xref>
###xml 932 939 912 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g004">Fig. 4B</xref>
###xml 1104 1111 1084 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g004">Fig. 4C</xref>
###xml 1581 1585 1556 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Capp1">[20]</xref>
###xml 1769 1776 1744 1751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g004">Fig. 4D</xref>
###xml 1913 1920 1888 1895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g004">Fig. 4B</xref>
###xml 2121 2125 2096 2100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Capp1">[20]</xref>
###xml 2335 2342 2310 2317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g004">Fig. 4D</xref>
###xml 438 443 <span type="species:ncbi:9606">human</span>
Considering the proposed role of Pollambda in DSB repair, we examined survival after ionizing radiation (IR) exposure of the different hamster cell lines described above (Fig. 3), expressing comparable levels of either R438 or W438 forms of hPollambda. Expression of the W438 variant conferred a significantly higher sensitivity to IR relative to control or R438 expressing cells (Fig. 4A). Identical results were obtained in transfected human MRC5 fibroblasts (Figure S3, partA). Interestingly, this HPRT hypersensitivity, induced by the presence of the W438 form, was not observed in a NHEJ-defective cell line (XRCC4KDcells) (Figure S3, partB), suggesting that the presence of the W438 hPollambda variant may result in a defective NHEJ. We therefore evaluated the effect of both hPollambda isoforms directly on the cellular NHEJ activity. Cellular models (C'10 and A'7 cell lines) with stably integrated NHEJ substrates [20, 36; Fig. 4B] were transfected by each isoform (R438 and W438 variant) to obtain cellular clones (C'R, C'W, A'R, A'W), expressing similar levels as confirmed by immunoblotting (Fig. 4C). The fragment generated after I-Sce-I transfection allows to measure deletion and inversion events. In the first cell line (C'10) the two I-Sce-I sites are in direct orientation resulting in CD4 expression after deletion events (the most frequent events) or CD8 expression after invertion events. Expression of the WT form of hPollambda (R438) did not affect the generation of deletion (CD4) and inversion (CD8) events relative to control cells as previously reported [20]. In contrast, expression of the W438 form (C'W clone) decreased by 2.5-fold the CD8 events (inversion) and by 3-fold the frequency of CD4 events (deletion) relative to control cells (Fig. 4D-left panel). This was confirmed by the use of an additional cell line (A'7) in which the two I-Sce-I sites are in inverted orientation (Fig. 4B) resulting in CD4 expression after deletion events (still the most frequent events) and CD8 expression after inversion events. Again, while no effect was shown with the WT form as previously observed [20], cells expressing the R438W variant (A'W) produced a significant decrease in the generation of deletion events (CD4) and inversion events (CD8) (4- and 3-fold decrease respectively relative to control cells) (Fig. 4D-right panel). These data demonstrate that expression of the W438 polymorphic variant of hPollambda decreases the cellular NHEJ activity, probably interfering with the maturation of both non-complementary and, at a lesser extend, complementary DNA ends during the repair of DSB generated by I-Sce-1.
###end p 34
###begin title 35
Defective NHEJ in cells expressing the polymorphic W438 hPollambda variant.
###end title 35
###begin p 36
###xml 101 109 96 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g003">Figure 3</xref>
###xml 204 207 199 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sce</italic>
(A) IR sensitivity of the DRA10 cell lines expressing the different forms of hPollambda described in Figure 3. (B) Substrate used to measure NHEJ (left panel) and representation of the sequences of the I-Sce-I restriction sites in the C'10 and A'7 cell lines (right panel). (C) Expression of the different forms (active: C'W, A'W; inactive: C'WD, A'WD) of W438 hPollambda in C'10 and A'7 analyzed by Western blot. (D) Evaluation of the deletion (CD4) and inversion (CD8) events in C'10 (left panel) and A'7 cells (right panel) expressing the empty vector (white bars) and the indicated W438 variant of hPollambda (grey bars). Results are the mean+/-SD of 3 independent experiments, *represent significant statistical difference (P<0.05), **represent significant statistical difference (P<0.005).
###end p 36
###begin title 37
Expression of the W438 hPollambda variant leads to chromosomal aberrations
###end title 37
###begin p 38
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Karanjawala1">[37]</xref>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Ferguson1">[38]</xref>
###xml 476 482 466 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g005">Fig. 5</xref>
###xml 756 762 741 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g005">Fig. 5</xref>
###xml 1064 1070 1039 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g005">Fig. 5</xref>
Since defects in the NHEJ pathway are known to lead to accumulation of chromosomal aberrations either spontaneously or after IR treatment [37], [38], we performed karyotypic analyses of the different cell lines described above. Examination of metaphase spreads showed a much higher generation of spontaneous or IR-induced chromosomal aberrations in cells expressing the W438 polymorphic variant of hPollambda relative to control cells or cells expressing the R438 hPollambda (Fig. 5). Dicentric and end-to-end chromatid fusion, hallmarks of a defective NHEJ, were the most common abnormalities seen in the W438 hPollambda expressing cells. We also found rings, triradial structures, and chromatid breaks (examples of some of these aberrations are given in Fig. 5). The level of spontaneous or IR-induced aneuploidy was also significantly enhanced in the W438 hPollambda expressing cells relative to control cells or cells expressing WT (R438) hPollambda. After IR, the effect is dramatic as aneuploidy reached 85% in the case of cells expressing the W438 variant (Fig. 5). Overall, these results show that expression of the W438 hPollambda induces major chromosomal instabilities, spontaneously or after IR treatment.
###end p 38
###begin title 39
Karyotype analysis of W438 hPollambda-expressing cells.
###end title 39
###begin p 40
(A) Increased chromosomal instability in W438 hPollambda-expressing cells. Metaphase spreads of either untreated (UT) or 2 Gy-treated (IR) cells corresponding to either control clones (DRA10 and CT2B), or to clones overexpressing either R438 (R1, R2) or the W438 variant (W1, W2) of hPollambda. (B) Examples of chromosomal aberrations observed in cells expressing the W438 variant of hPollambda.
###end p 40
###begin title 41
Requirement of a functional DNA polymerase activity for the W438-associated phenotypes
###end title 41
###begin p 42
###xml 342 349 332 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 393 396 383 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz3">[8]</xref>
###xml 502 509 487 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g006">Fig. 6A</xref>
###xml 622 643 607 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 695 703 680 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g006">Figure 6</xref>
###xml 879 886 864 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g006">Fig. 6B</xref>
###xml 917 924 902 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g006">Fig. 6C</xref>
###xml 960 967 945 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007290-g006">Fig. 6D</xref>
###xml 342 349 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
A cDNA coding for a catalytically inactive form of hPollambda, in which two catalytic aspartates (D427 and D429) were changed to Ala, was obtained by site-directed mutagenesis on the pRSETB plasmid carrying the cDNA sequence of the variant W438 hPollambda gene. This construct was used to overproduce the inactive (dead) variant W438 (WD) in E. coli, that was purified as previously described [8]. As expected, DNA polymerization activity in the mutant form (WD) of the hPollambda W438 was negligible (Fig. 6A). The corresponding cDNA was transferred to the pIRES vector, and transfected into DRA10 cells, as described in Materials and Methods, to obtain the "dead" mutant clone WD. As shown in Figure 6, all the phenotypes associated with expression of the W438 variant were abolished when the inactive WD mutant was expressed. Thus, mutant WD displayed a normal NHEJ activity (Fig. 6B), a normal sensitivity to IR (Fig. 6C), and a normal karyotype analysis (Fig. 6D).
###end p 42
###begin title 43
Requirement of a functional DNA polymerase activity for the W438-associated phenotypes.
###end title 43
###begin p 44
###xml 264 285 259 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
(A) DNA polymerization activity of the mutant form (WD) of the hPollambda W438 was negligible in comparison to that of the natural variants R438 and W438. All the phenotypes associated with expression of the W438 variant into DRA10 cells (analyzed as described in Materials and Methods) were abolished when the inactive WD mutant was expressed. Thus, mutant WD displayed a normal NHEJ activity (B), a normal sensitivity to IR (C), and a normal karyotype analysis (D).
###end p 44
###begin p 45
That indicates that the observed phenotyes intrinsically depend on the polymerization capacity of the variant DNA polymerase, but not indirectly due to any DNA repair disbalance produced by eventual titration (via protein:protein interactions) of NHEJ factors by the overproduced polymerase. Therefore, it must be assumed that the more frequent errors made by the polymerase variant are the direct responsible for the observed phenotypes.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">POLL</italic>
###xml 310 318 310 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 568 576 558 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
We describe here a coding SNP in exon 8 of the POLL gene resulting in an amino acid substitution at position 438, coding for a tryptophan (W) instead of an arginine (R). This polymorphism did not affect dramatically the protein structure at the polymerization active site and consistent with this observation, in vitro assays using purified hPollambda forms R438 and W438 did not show significant differences neither in polymerase and dRP lyase activities, nor in reconstituted BER reactions. However, we found that purified W438 hPollambda displays higher error rate in vitro, and that its expression in mammalian cells severely affects maintenance of the genome stability by enhancing mutation frequency, by compromising NHEJ, and by generating spontaneous or IR-induced chromosomal aberrations. We also prove that the observed defects are directly linked to the activity of the polymerase ruling out the hypothesis of any effect of imbalance in protein/protein interactions. How does the reduced fidelity of the W438 variant could affect NHEJ and chromosome instability? Whereas the overall effects observed on NHEJ efficiency and chromosomal instability are very dramatic, it is not obvious that they might be simply due to the observed/quantified effect (3-8 fold) on nucleotide insertion fidelity. However, it is important to emphasize that although the fidelity measurements are given as a mean value, figures can be higher when considering particular mismatches, and they can be even much higher when considering mismatches made in a particular sequence context (hot spots). On the other hand, reduced polymerization accuracy may have a more drastic effect during NHEJ, as the errors introduced during such unstable gap-filling synthesis could hinder ligation, the final step of the repair pathway. Alternatively, we cannot rule out the possibility that the W438 mutation affects the direct interaction of this variant Pol lambda with some other NHEJ factors.
###end p 47
###begin p 48
###xml 624 628 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Albertella1">[39]</xref>
###xml 1134 1138 1134 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Gorgoulis1">[40]</xref>
###xml 611 616 <span type="species:ncbi:9606">human</span>
###xml 695 703 <span type="species:ncbi:9606">patients</span>
Interestingly, restriction fragment length polymorphism (RFLP) analysis of a collection of above 300 cases-control indicated that the W438 variant is associated to rectal cancer, and the allelic frequency of the W438 allele is 0.27 in the caucasian population (manuscript in preparation). The findings shown here demonstrate that overexpression of a cancer-related natural variant of one specialized DNA polymerase can be associated to genetic instability at the chromosomal level, probably due to a defective NHEJ. There is evidence that overexpression of Pol lambda, as well as Pol beta, occurs frequently in human tumors [39]. Analysis of the heterozygote population R/W in colorectal cancer patients shows that both alleles are expressed at the same level (our unpublished data). Therefore, expression of the W438 allele does not likely affect the global DSB repair capacity in these heterozygots in a normal physiological situation, but may predispose the cells, perhaps due to DNA repair fidelity issues, to accumulate chromosomal aberrations when excessive DSBs are generated, as it occurs in pre-cancerous hyperplasia tissues [40], or when an additional factor involved in DSB repair is altered.
###end p 48
###begin p 49
###xml 242 246 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Shah1">[35]</xref>
###xml 248 252 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Dobashi1">[21]</xref>
###xml 253 257 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Lang1">[23]</xref>
###xml 259 263 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Miyamoto1">[41]</xref>
###xml 265 269 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Wang1">[42]</xref>
###xml 446 450 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Sweasy1">[24]</xref>
###xml 452 456 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Dalal1">[32]</xref>
###xml 1054 1058 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Goldsby1">[43]</xref>
###xml 1457 1461 1439 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Hanahan1">[44]</xref>
###xml 495 500 <span type="species:ncbi:9606">human</span>
###xml 619 624 <span type="species:ncbi:9606">human</span>
###xml 1049 1053 <span type="species:ncbi:10090">mice</span>
###xml 1067 1072 <span type="species:ncbi:9606">human</span>
In spite of their key role in DNA repair, polymorphic forms of DNA repair polymerases have been poorly described, except in several studies carried out with Poliota and Polbeta, where a significant number of genetic alterations were reported [35], [21]-[23], [41], [42]. More recently, an association between the presence of altered forms of Polbeta and their overall DNA repair capacity, resulting in cellular transformation, has been described [24], [32]. Identification of which mutations in human genes are determining the genetic basis of diseases is a challenge. In this sense, the vast data generated during the human genome project only provide a minimal help to establish the relationship between sequence variation and susceptibility to disease. In addition to polymorphisms that are simply associated to causative mutations, those responsible for functional differences that directly contribute to disease are of greater importance. Loss of proofreading by a replicative polymerase as Poldelta increases spontaneous tumour development in mice [43]. Is the human Pollambda mutation W438 actually causative or contributory to oncogenesis? Although we do have shown an association of this mutation with rectal cancer (manuscript in preparation), it is unlikely that this sole mutation is causative to oncogenesis, but it could contribute to enhance genetic instability, one of the major hallmark in cancer cells. As proposed by Hanahan and Weinberg [44], a variant DNA repair enzyme, as that described here, might accelerate carcinogenesis by increasing genetic instability, at the nucleotide as well as at the chromosomal levels, which in turn confers a selective growth advantage during cancer-cell evolution.
###end p 49
###begin title 50
Materials and Methods
###end title 50
###begin title 51
PCR-SSCP, cloning and sequencing
###end title 51
###begin p 52
###xml 305 328 295 318 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;TAGCTTGGCCAGTAGTCGACC</named-content>
###xml 346 367 331 352 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GAAGGGAGCTCAGCCACTC</named-content>
###xml 384 407 364 387 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;ATACTTCAATGGATCCCAGGG</named-content>
###xml 425 445 400 420 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;TTGGGTGTTTGGTGCCTC</named-content>
###xml 462 482 432 452 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GAGGCACCAAACACCCAA</named-content>
###xml 500 523 465 488 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;TCCACTTGTCTCCCTGAACAC</named-content>
###xml 540 562 500 522 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;TCCATAAGCCTGTCACCTCG</named-content>
###xml 581 603 536 558 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GGGCATACGTTCCAGGAAG</named-content>
###xml 844 845 791 792 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1098 1102 1027 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Tomka1">[45]</xref>
###xml 1104 1108 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Kirchhoff1">[46]</xref>
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 866 872 <span type="species:ncbi:9913">bovine</span>
A panel of cDNAs from normal and tumoral human tissues (Clontech) was used as a template to search for possible genetic alterations in the hPollambda gene. The set of overlapping primers selected was used to cover the entire coding sequence of the gene. The sequences of primers used were: hPollambdaex1s:5'TAGCTTGGCCAGTAGTCGACC; hPollambdaex3as:5'GAAGGGAGCTCAGCCACTC; hPollambdaex2s:5'ATACTTCAATGGATCCCAGGG; hPollambdaex4as:5'TTGGGTGTTTGGTGCCTC; hPollambdaex4s:5'GAGGCACCAAACACCCAA; hPollambdaex5as:5'TCCACTTGTCTCCCTGAACAC; hPollambdaex5s:5'TCCATAAGCCTGTCACCTCG; hPollambdaex7as: 5' GGGCATACGTTCCAGGAAG. cDNA templates were 5-fold diluted and the resulting aliquot was used as 5x stock for PCR. All PCR reactions (10 microl) were conducted using 1 microM of each primer, 0.25 mM dNTPs, 1x Taq buffer (10 mM Tris pH 8.5, 50 mM NaCl, 1,5 mM MgCl2, gelatin, 0.2 mg/ml bovine serum albumin (BSA)) and 0.25 U of Taq polymerase. Cycle parameters were as follows: 94degreesC, 15 s; 62degreesC, 30 s; 72degreesC, 15 s; 35 cycles. PCR products were then subjected to SSCP analysis carried out as described [45], [46]. Fragments exhibiting altered mobility patterns were cloned into the TA cloning vector pCRII (Invitrogen) and sequenced on an ABI 373 (Applied Biosystems) automatic sequencer.
###end p 52
###begin title 53
Enzymes, DNA substrates and nucleotides
###end title 53
###begin p 54
###xml 194 196 190 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 210 212 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 227 229 215 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 247 249 231 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 443 450 422 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 477 480 456 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz3">[8]</xref>
###xml 170 174 <span type="species:ncbi:9913">calf</span>
###xml 371 376 <span type="species:ncbi:9606">Human</span>
###xml 443 450 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 482 487 <span type="species:ncbi:9606">Human</span>
Synthetic oligonucleotides purified by polyacrylamide gel electrophoresis (PAGE) were obtained from Life Technologies. Ultrapure deoxynucleoside triphosphates, activated calf thymus DNA, [gamma-32P]ATP, [alpha-32P]dATP, [alpha-32P]dCTP and [alpha-32P]ddATP (3000 Ci/mmol) were from Amersham Pharmacia Biotech. Terminal deoxynucleotidiltransferase (TdT) was from Promega. Human recombinant Pollambda (R438 and W438 forms) were overexpressed in E. coli and purified as described [8]. Human uracil DNA glycosilase (hUDG) and hAPE were generous gifts of Dr. Samuel H. Wilson (NIEHS, NC). T4 polynucleotide kinase (PNK) was from New England Biolabs.
###end p 54
###begin title 55
DNA polymerization assays
###end title 55
###begin p 56
###xml 60 63 60 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz3">[8]</xref>
###xml 485 489 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Picher1">[47]</xref>
Reactions on activated DNA were carried out as described in [8] and were initiated by adding either the indicated or a fixed amount (60 ng; 35 nM) of each hPollambda variant, in the presence of different concentrations of the indicated dNTPs. Polymerization activity, determined as total dNMP incorporated, was calculated from the amount of radioactivity present in the excluded volume, determined by counting Cerenkov radiation. Primer extension assays were performed as described in [47] with 100 nM of either hPollambda R or hPollambda W and the indicated concentration of dNTP and incubated at 37degreesC for 20 min.
###end p 56
###begin title 57
###xml 22 30 22 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
dRPlyase activity and in vitro reconstitution of BER
###end title 57
###begin p 58
###xml 49 52 49 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz4">[9]</xref>
Reactions were performed as previously described [9]. The reaction was initiated by adding different amounts of R438 or W438 forms and incubated for 20 min at 37degreesC.
###end p 58
###begin title 59
Fidelity assays
###end title 59
###begin p 60
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Osheroff1">[27]</xref>
###xml 157 158 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 557 564 534 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 621 625 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Bebenek1">[48]</xref>
###xml 557 564 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
The base substitution reversion assay was performed as described [27]. Gap-filling reaction mixtures (20 microl) contained 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM dithiothreitol, 2 microg of BSA, 4% glycerol, 1.6 nM gapped DNA, 500 microM each of dATP, dGTP, dCTP, and dTTP, 400 units of T4 DNA ligase, and 100 nM hPollambda (either R438 or W438 forms). After 1 h incubation at 37degreesC, the products were separated on an agarose gel, and the covalently closed circular DNA products were electroeluted from gel slices. DNA products were introduced into E. coli by electroporation and followed by plating as described [48].
###end p 60
###begin title 61
Generation of hPollambda overexpressing cells
###end title 61
###begin p 62
###xml 405 409 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Capp1">[20]</xref>
###xml 761 764 722 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz1">[4]</xref>
hPollambda expressing plasmids pIRES-hPollambda R438 and pIRES-hPollambda W438 were constructed by PCR amplification from a pRSETB plasmid carrying the cDNA sequences of either the wild-type hPollambda gene (R438 form) or the variant W438 hPollambda gene, respectively, and cloning into pIRES vector (Clontech). The construction of a catalyticaly inactive mutant of W438 (WD) was carried out as described [20]. Upon transfection in CHO-DRA10, XR-1 (XRCC4 mutant cells), and MRC5 cell lines, different clones (DRA10-R1; DRA10-R2; DRA10-W1; DRA10-W2; MRC5-R; MRC5-W; XR-1-W1; XR-1-W2) were obtained. Expression of the different hPollambda protein variants was measured by immunoblotting of total cellular extracts (75 microg) with Pollambda polyclonal antibodies [4] and the actin antibodies AC-40 (Sigma-Aldrich Chemical Co).
###end p 62
###begin title 63
Mutagenesis assay in mammalian cells
###end title 63
###begin p 64
###xml 106 107 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
For determination of spontaneous mutagenesis, replica cultures of cells were plated at the density of 5x105 cells by plate (5 plates per experiment) and exposed to 20 microM of 6-thioguanine (6-TG) containing media in order to determine the number of HPRT mutants that are resistant to 6-TG treatment. After 8 days, plates were stained and macroscopic colonies of more than 50 cells were scored and mutation frequencies were calculated by correcting for plating efficiency.
###end p 64
###begin title 65
Cytotoxicity studies
###end title 65
###begin p 66
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Capp1">[20]</xref>
Cytotoxicity of ionizing radiation was determined by clonogenic assay [20]. Survival was expressed as the plating efficiency of treated cells relative to the untreated control cells. Results are the mean+/-SD of 3 independent experiments.
###end p 66
###begin title 67
Measurement of cellular NHEJ activity
###end title 67
###begin p 68
###xml 43 47 43 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Capp1">[20]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-GarciaDiaz5">[34]</xref>
NHEJ activity was measured as described in [20]. The C'10 and A'7 cell lines were cultured in DMEM medium (GIBCO BRL, France) as previously described [34]. The C'W and A'7W clones, and the C'WD and A'7WD clones were obtained after transfection with the pIRESpuro2 vector (Clontech) containing the cDNA coding for the W438 hPollambda (W) or the inactive form of the W438 hPollambda (WD), respectively. Individual clones were obtained after transfection with jetPEI (Qbiogen, Illkirch, France) and selection with puromycin (5 microg/mL).
###end p 68
###begin title 69
Karyotype analyses
###end title 69
###begin p 70
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007290-Bergoglio1">[49]</xref>
Cells were unirradiated or irradiated at 2 Gy as described previously. Karyotype analyses were performed as described in [49]. Chromosomal distributions and aberration percentages included the analysis of at least 100 metaphases spreads for each experiment.
###end p 70
###begin title 71
Supporting Information
###end title 71
###begin p 72
###xml 262 283 257 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
TLS of 8oxoG lesions by hPollambda variants R438 and W438.The scheme shows the sequence of the DNA used to analyze nucleotide insertion reactions opposite dG or 8oxoG (A) or extension of primers paired to 8oxoG (B). Reactions were carried out as described under Materials and Methods, with 100 nM of either R438 or W438 isoforms of hPollambda, and using 1 microM of each indicated dNTP (A) or the indicated concentrations of dG (B). Extension of the 5' end labeled primer (*) was examined by PAGE.
###end p 72
###begin p 73
(4.91 MB EPS)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
Location of the R438 residue in the crystal structure of hPollambda. Ribbon representation of the ternary pre-catalytic complex of hPollambda (PDBid 1XSN). Arg438 (magenta; pointed with an arrow) is located in a loop (shown in green) in the palm subdomain. This loop is next to the N-terminal end of alpha-helix M. Both alpha-helices M and N (shown in dark gray) are critical to position the substrates and assemble the nascent base pair binding pocket. The DNA duplex is shown in light blue. The templating base is yellow and the incoming ddTTP is red.
###end p 75
###begin p 76
(5.26 MB EPS)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
Cell survival after ionizing radiation. Cell survival after ionizing radiation for MRC5 control cells (MRC5), or expressing the R438 (MRC5-R) or W438 (MRC5-W) forms of hPollambda (A), and for NHEJ-defective cells (XRCC4-defficient), control (XR-1), complemented by XRCC4 (X4-V; 20), or expressing the W438 (XR-1-W1; XR-1-W2) form of hPollambda (B).
###end p 78
###begin p 79
(4.79 MB EPS)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin title 81
References
###end title 81
###begin article-title 82
Genome maintenance mechanisms for preventing cancer.
###end article-title 82
###begin article-title 83
Eukaryotic DNA polymerases.
###end article-title 83
###begin article-title 84
Functions of eukaryotic DNA polymerases.
###end article-title 84
###begin article-title 85
DNA polymerase lambda (Pol lambda), a novel eukaryotic DNA polymerase with a potential role in meiosis.
###end article-title 85
###begin article-title 86
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
Two novel human and mouse DNA polymerases of the polX family.
###end article-title 86
###begin article-title 87
###xml 39 44 <span type="species:ncbi:9606">human</span>
Identification and characterization of human DNA polymerase beta 2, a DNA polymerase beta -related enzyme.
###end article-title 87
###begin article-title 88
A structural solution for the DNA polymerase lambda-dependent repair of DNA gaps with minimal homology.
###end article-title 88
###begin article-title 89
###xml 52 57 <span type="species:ncbi:9606">human</span>
DNA polymerase lambda, a novel DNA repair enzyme in human cells.
###end article-title 89
###begin article-title 90
###xml 76 81 <span type="species:ncbi:9606">human</span>
Identification of an intrinsic 5'-deoxyribose-5-phosphate lyase activity in human DNA polymerase lambda: a possible role in base excision repair.
###end article-title 90
###begin article-title 91
Structural design of a eukaryotic DNA repair polymerase: DNA polymerase beta.
###end article-title 91
###begin article-title 92
Mammalian DNA beta-polymerase in base excision repair of alkylation damage.
###end article-title 92
###begin article-title 93
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
DNA polymerase lambda protects mouse fibroblasts against oxidative DNA damage and is recruited to sites of DNA damage/repair.
###end article-title 93
###begin article-title 94
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
DNA polymerase lambda mediates a back-up base excision repair activity in extracts of mouse embryonic fibroblasts.
###end article-title 94
###begin article-title 95
From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair.
###end article-title 95
###begin article-title 96
A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins.
###end article-title 96
###begin article-title 97
DNA polymerase lambda can elongate on DNA substrates mimicking non-homologous end joining and interact with XRCC4-ligase IV complex.
###end article-title 97
###begin article-title 98
A biochemically defined system for mammalian nonhomologous DNA end joining.
###end article-title 98
###begin article-title 99
A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomologous end joining.
###end article-title 99
###begin article-title 100
###xml 105 110 <span type="species:ncbi:9606">human</span>
Implication of DNA polymerase lambda in alignment-based gap filling for nonhomologous DNA end joining in human nuclear extracts.
###end article-title 100
###begin article-title 101
The DNA polymerase lambda is required for the repair of non-compatible DNA double strand breaks by NHEJ in mammalian cells.
###end article-title 101
###begin article-title 102
###xml 21 26 <span type="species:ncbi:9606">human</span>
Polymorphisms in the human DNA polymerase beta gene.
###end article-title 102
###begin article-title 103
A variant of DNA polymerase beta acts as a dominant negative mutant.
###end article-title 103
###begin article-title 104
A DNA polymerase beta mutant from colon cancer cells induces mutations.
###end article-title 104
###begin article-title 105
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Expression of DNA polymerase {beta} cancer-associated variants in mouse cells results in cellular transformation.
###end article-title 105
###begin article-title 106
Considering the cancer consequences of altered DNA polymerase function.
###end article-title 106
###begin article-title 107
Active site mutation in DNA polymerase gamma associated with progressive external ophthalmoplegia causes error-prone DNA synthesis.
###end article-title 107
###begin article-title 108
The fidelity of DNA polymerase beta during distributive and processive DNA synthesis.
###end article-title 108
###begin article-title 109
Minor groove interactions at the DNA polymerase beta active site modulate single-base deletion error rates.
###end article-title 109
###begin article-title 110
The E249K mutator mutant of DNA polymerase beta extends mispaired termini.
###end article-title 110
###begin article-title 111
The mutator form of polymerase beta with amino acid substitution at tyrosine 265 in the hinge region displays an increase in both base substitution and frame shift errors.
###end article-title 111
###begin article-title 112
Base substitution specificity of DNA polymerase beta depends on interactions in the DNA minor groove.
###end article-title 112
###begin article-title 113
Prostate-cancer-associated I260M variant of DNA polymerase beta is a sequence-specific mutator.
###end article-title 113
###begin article-title 114
Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs.
###end article-title 114
###begin article-title 115
A closed conformation for the Pol lambda catalytic cycle.
###end article-title 115
###begin article-title 116
A DNA polymerase beta mutator mutant with reduced nucleotide discrimination and increased protein stability.
###end article-title 116
###begin article-title 117
Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells.
###end article-title 117
###begin article-title 118
The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts.
###end article-title 118
###begin article-title 119
The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations.
###end article-title 119
###begin article-title 120
The overexpression of specialized DNA polymerases in cancer.DNA Repair (Amst).
###end article-title 120
###begin article-title 121
###xml 67 72 <span type="species:ncbi:9606">human</span>
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.
###end article-title 121
###begin article-title 122
###xml 37 42 <span type="species:ncbi:9606">human</span>
DNA polymerase beta gene mutation in human breast cancer.
###end article-title 122
###begin article-title 123
###xml 33 38 <span type="species:ncbi:9606">human</span>
DNA polymerase beta mutations in human colorectal cancer.
###end article-title 123
###begin article-title 124
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice.
###end article-title 124
###begin article-title 125
The hallmarks of cancer.
###end article-title 125
###begin article-title 126
The combination of heteroduplex analysis and protein truncation test for exact detection of the APC gene mutations.
###end article-title 126
###begin article-title 127
Characterization of APC exon 15 germ-line mutation in FAP family with severe phenotype showing extracolonic symptoms.
###end article-title 127
###begin article-title 128
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human DNA polymerase lambda is a proficient extender of primer ends paired to 7,8-dihydro-8-oxoguanine.
###end article-title 128
###begin article-title 129
Analyzing fidelity of DNA polymerases.
###end article-title 129
###begin article-title 130
Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis.
###end article-title 130
###begin p 131
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 131
###begin p 132
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by Ministerio de Ciencia y Tecnologia Grants BFU2006-14390/BMC, CONSOLIDER CSD2007-00015 and Comunidad Autonoma de Madrid Grants P2006/BIO-0306 to L.B., by INCa "Checkpol", ARC, and "Ligue contre le Cancer (Region Midi-Pyrenees)" to J-S.H., by the Division of Intramural Research, NIEHS, NIH, DHHS to T.A.K., by SAF2002-02265 to A.V., and by an institutional grant to Centro de Biologia Molecular "Severo Ochoa" from Fundacion Ramon Areces. G.T. was recipient of a fellowship from the Ministerio de Educacion y Ciencia. A.V. is an Investigator of the Ramon y Cajal Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 132

